U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06945484) titled 'PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study' on April 18.
Brief Summary: This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
NSCLC Stage II
NSCLC, Stage III
Intervention:
OTHER: Precision Exercise Regimen for Cancer Care (PERCC)
PERCC has exercise modes including basic transfer and calisthenics mobility, aerobic, and resistance exercises, and wil...